84 related articles for article (PubMed ID: 12704544)
1. Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins.
Laham RJ; Li J; Tofukuji M; Post M; Simons M; Sellke FW
Ann Vasc Surg; 2003 May; 17(3):245-52. PubMed ID: 12704544
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response.
Lopez JJ; Laham RJ; Carrozza JP; Tofukuji M; Sellke FW; Bunting S; Simons M
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1317-23. PubMed ID: 9321821
[TBL] [Abstract][Full Text] [Related]
3. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium.
Sellke FW; Wang SY; Stamler A; Lopez JJ; Li J; Li J; Simons M
Am J Physiol; 1996 Aug; 271(2 Pt 2):H713-20. PubMed ID: 8770115
[TBL] [Abstract][Full Text] [Related]
4. Vasodilation to vascular endothelial growth factor in the uterine artery of the pregnant rat is blunted by low dietary protein intake.
Itoh S; Brawley L; Wheeler T; Anthony FW; Poston L; Hanson MA
Pediatr Res; 2002 Apr; 51(4):485-91. PubMed ID: 11919334
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor causes pulmonary vasodilation through activation of the phosphatidylinositol-3-kinase-nitric oxide pathway in the late-gestation ovine fetus.
Grover TR; Zenge JP; Parker TA; Abman SH
Pediatr Res; 2002 Dec; 52(6):907-12. PubMed ID: 12438669
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.
Sato K; Wu T; Laham RJ; Johnson RB; Douglas P; Li J; Sellke FW; Bunting S; Simons M; Post MJ
J Am Coll Cardiol; 2001 Feb; 37(2):616-23. PubMed ID: 11216988
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor administration in chronic myocardial ischemia.
Harada K; Friedman M; Lopez JJ; Wang SY; Li J; Prasad PV; Pearlman JD; Edelman ER; Sellke FW; Simons M
Am J Physiol; 1996 May; 270(5 Pt 2):H1791-802. PubMed ID: 8928888
[TBL] [Abstract][Full Text] [Related]
8. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia.
Tofukuji M; Metais C; Li J; Franklin A; Simons M; Sellke FW
Circulation; 1998 Nov; 98(19 Suppl):II242-6; discussion II247-8. PubMed ID: 9852909
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic modulation of the collateral-dependent coronary microcirculation.
Sellke FW; Wang SY; Friedman M; Dai HB; Harada K; Lopez JJ; Simons M
J Surg Res; 1995 Jul; 59(1):185-90. PubMed ID: 7630126
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries.
Sudhir K; Chou TM; Mullen WL; Hausmann D; Collins P; Yock PG; Chatterjee K
J Am Coll Cardiol; 1995 Sep; 26(3):807-14. PubMed ID: 7642876
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of vascular growth factors on arterial and venous angiogenesis.
Blebea J; Vu JH; Assadnia S; McLaughlin PJ; Atnip RG; Zagon IS
J Vasc Surg; 2002 Mar; 35(3):532-8. PubMed ID: 11877704
[TBL] [Abstract][Full Text] [Related]
12. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
[TBL] [Abstract][Full Text] [Related]
13. VEGF administration in chronic myocardial ischemia in pigs.
Lopez JJ; Laham RJ; Stamler A; Pearlman JD; Bunting S; Kaplan A; Carrozza JP; Sellke FW; Simons M
Cardiovasc Res; 1998 Nov; 40(2):272-81. PubMed ID: 9893720
[TBL] [Abstract][Full Text] [Related]
14. Interaction between adenosine and flow-induced dilation in coronary microvascular network.
Liao JC; Kuo L
Am J Physiol; 1997 Apr; 272(4 Pt 2):H1571-81. PubMed ID: 9139938
[TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S
Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women.
Svedas E; Islam KB; Nisell H; Kublickiene KR
Am J Obstet Gynecol; 2003 Jan; 188(1):168-76. PubMed ID: 12548213
[TBL] [Abstract][Full Text] [Related]
17. Effects of B-type natriuretic peptide (nesiritide) on coronary epicardial arteries, systemic vasculature and microvessels.
Wu GF; Wykrzykowska JJ; Rana JS; Pinto DS; Gibson CM; Li J; Sellke FW; Laham RJ
J Invasive Cardiol; 2008 Feb; 20(2):76-80. PubMed ID: 18252972
[TBL] [Abstract][Full Text] [Related]
18. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
[TBL] [Abstract][Full Text] [Related]
19. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
